Medical Care
Global Radiolabelled ADME Studies Market Research Report 2025
- Jan 16, 26
- ID: 675512
- Pages: 91
- Figures: 96
- Views: 9
This report aims to provide a comprehensive presentation of the global market for Radiolabelled ADME Studies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiolabelled ADME Studies.
The Radiolabelled ADME Studies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiolabelled ADME Studies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiolabelled ADME Studies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Eurofins Scientific
Evotec
Labcorp
Sekisui Medical
XenoTech (BioIVT)
QPS
BioDuro-Sundia
Quotient Sciences
Chelatec
HMR
Nuvisan
Fluorizon
WuXi AppTec
Pharmaron
InnoStar
Medicilon
Frontage
Value Pharmaceutical
New Radiomedicine Technology
Segment by Type
C-14
H-3
Others
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiolabelled ADME Studies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Radiolabelled ADME Studies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiolabelled ADME Studies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiolabelled ADME Studies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Eurofins Scientific
Evotec
Labcorp
Sekisui Medical
XenoTech (BioIVT)
QPS
BioDuro-Sundia
Quotient Sciences
Chelatec
HMR
Nuvisan
Fluorizon
WuXi AppTec
Pharmaron
InnoStar
Medicilon
Frontage
Value Pharmaceutical
New Radiomedicine Technology
Segment by Type
C-14
H-3
Others
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiolabelled ADME Studies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiolabelled ADME Studies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 C-14
1.2.3 H-3
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiolabelled ADME Studies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiolabelled ADME Studies Market Perspective (2020-2031)
2.2 Global Radiolabelled ADME Studies Growth Trends by Region
2.2.1 Global Radiolabelled ADME Studies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiolabelled ADME Studies Historic Market Size by Region (2020-2025)
2.2.3 Radiolabelled ADME Studies Forecasted Market Size by Region (2026-2031)
2.3 Radiolabelled ADME Studies Market Dynamics
2.3.1 Radiolabelled ADME Studies Industry Trends
2.3.2 Radiolabelled ADME Studies Market Drivers
2.3.3 Radiolabelled ADME Studies Market Challenges
2.3.4 Radiolabelled ADME Studies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiolabelled ADME Studies Players by Revenue
3.1.1 Global Top Radiolabelled ADME Studies Players by Revenue (2020-2025)
3.1.2 Global Radiolabelled ADME Studies Revenue Market Share by Players (2020-2025)
3.2 Global Radiolabelled ADME Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiolabelled ADME Studies Revenue
3.4 Global Radiolabelled ADME Studies Market Concentration Ratio
3.4.1 Global Radiolabelled ADME Studies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiolabelled ADME Studies Revenue in 2024
3.5 Global Key Players of Radiolabelled ADME Studies Head office and Area Served
3.6 Global Key Players of Radiolabelled ADME Studies, Product and Application
3.7 Global Key Players of Radiolabelled ADME Studies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiolabelled ADME Studies Breakdown Data by Type
4.1 Global Radiolabelled ADME Studies Historic Market Size by Type (2020-2025)
4.2 Global Radiolabelled ADME Studies Forecasted Market Size by Type (2026-2031)
5 Radiolabelled ADME Studies Breakdown Data by Application
5.1 Global Radiolabelled ADME Studies Historic Market Size by Application (2020-2025)
5.2 Global Radiolabelled ADME Studies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiolabelled ADME Studies Market Size (2020-2031)
6.2 North America Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiolabelled ADME Studies Market Size by Country (2020-2025)
6.4 North America Radiolabelled ADME Studies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiolabelled ADME Studies Market Size (2020-2031)
7.2 Europe Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiolabelled ADME Studies Market Size by Country (2020-2025)
7.4 Europe Radiolabelled ADME Studies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiolabelled ADME Studies Market Size (2020-2031)
8.2 Asia-Pacific Radiolabelled ADME Studies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiolabelled ADME Studies Market Size (2020-2031)
9.2 Latin America Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiolabelled ADME Studies Market Size by Country (2020-2025)
9.4 Latin America Radiolabelled ADME Studies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiolabelled ADME Studies Market Size (2020-2031)
10.2 Middle East & Africa Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiolabelled ADME Studies Introduction
11.1.4 Charles River Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Radiolabelled ADME Studies Introduction
11.2.4 Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Radiolabelled ADME Studies Introduction
11.3.4 Evotec Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.3.5 Evotec Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Details
11.4.2 Labcorp Business Overview
11.4.3 Labcorp Radiolabelled ADME Studies Introduction
11.4.4 Labcorp Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.4.5 Labcorp Recent Development
11.5 Sekisui Medical
11.5.1 Sekisui Medical Company Details
11.5.2 Sekisui Medical Business Overview
11.5.3 Sekisui Medical Radiolabelled ADME Studies Introduction
11.5.4 Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.5.5 Sekisui Medical Recent Development
11.6 XenoTech (BioIVT)
11.6.1 XenoTech (BioIVT) Company Details
11.6.2 XenoTech (BioIVT) Business Overview
11.6.3 XenoTech (BioIVT) Radiolabelled ADME Studies Introduction
11.6.4 XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.6.5 XenoTech (BioIVT) Recent Development
11.7 QPS
11.7.1 QPS Company Details
11.7.2 QPS Business Overview
11.7.3 QPS Radiolabelled ADME Studies Introduction
11.7.4 QPS Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.7.5 QPS Recent Development
11.8 BioDuro-Sundia
11.8.1 BioDuro-Sundia Company Details
11.8.2 BioDuro-Sundia Business Overview
11.8.3 BioDuro-Sundia Radiolabelled ADME Studies Introduction
11.8.4 BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.8.5 BioDuro-Sundia Recent Development
11.9 Quotient Sciences
11.9.1 Quotient Sciences Company Details
11.9.2 Quotient Sciences Business Overview
11.9.3 Quotient Sciences Radiolabelled ADME Studies Introduction
11.9.4 Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.9.5 Quotient Sciences Recent Development
11.10 Chelatec
11.10.1 Chelatec Company Details
11.10.2 Chelatec Business Overview
11.10.3 Chelatec Radiolabelled ADME Studies Introduction
11.10.4 Chelatec Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.10.5 Chelatec Recent Development
11.11 HMR
11.11.1 HMR Company Details
11.11.2 HMR Business Overview
11.11.3 HMR Radiolabelled ADME Studies Introduction
11.11.4 HMR Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.11.5 HMR Recent Development
11.12 Nuvisan
11.12.1 Nuvisan Company Details
11.12.2 Nuvisan Business Overview
11.12.3 Nuvisan Radiolabelled ADME Studies Introduction
11.12.4 Nuvisan Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.12.5 Nuvisan Recent Development
11.13 Fluorizon
11.13.1 Fluorizon Company Details
11.13.2 Fluorizon Business Overview
11.13.3 Fluorizon Radiolabelled ADME Studies Introduction
11.13.4 Fluorizon Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.13.5 Fluorizon Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Radiolabelled ADME Studies Introduction
11.14.4 WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.14.5 WuXi AppTec Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Radiolabelled ADME Studies Introduction
11.15.4 Pharmaron Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.15.5 Pharmaron Recent Development
11.16 InnoStar
11.16.1 InnoStar Company Details
11.16.2 InnoStar Business Overview
11.16.3 InnoStar Radiolabelled ADME Studies Introduction
11.16.4 InnoStar Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.16.5 InnoStar Recent Development
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Radiolabelled ADME Studies Introduction
11.17.4 Medicilon Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.17.5 Medicilon Recent Development
11.18 Frontage
11.18.1 Frontage Company Details
11.18.2 Frontage Business Overview
11.18.3 Frontage Radiolabelled ADME Studies Introduction
11.18.4 Frontage Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.18.5 Frontage Recent Development
11.19 Value Pharmaceutical
11.19.1 Value Pharmaceutical Company Details
11.19.2 Value Pharmaceutical Business Overview
11.19.3 Value Pharmaceutical Radiolabelled ADME Studies Introduction
11.19.4 Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.19.5 Value Pharmaceutical Recent Development
11.20 New Radiomedicine Technology
11.20.1 New Radiomedicine Technology Company Details
11.20.2 New Radiomedicine Technology Business Overview
11.20.3 New Radiomedicine Technology Radiolabelled ADME Studies Introduction
11.20.4 New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.20.5 New Radiomedicine Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiolabelled ADME Studies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 C-14
1.2.3 H-3
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiolabelled ADME Studies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiolabelled ADME Studies Market Perspective (2020-2031)
2.2 Global Radiolabelled ADME Studies Growth Trends by Region
2.2.1 Global Radiolabelled ADME Studies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiolabelled ADME Studies Historic Market Size by Region (2020-2025)
2.2.3 Radiolabelled ADME Studies Forecasted Market Size by Region (2026-2031)
2.3 Radiolabelled ADME Studies Market Dynamics
2.3.1 Radiolabelled ADME Studies Industry Trends
2.3.2 Radiolabelled ADME Studies Market Drivers
2.3.3 Radiolabelled ADME Studies Market Challenges
2.3.4 Radiolabelled ADME Studies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiolabelled ADME Studies Players by Revenue
3.1.1 Global Top Radiolabelled ADME Studies Players by Revenue (2020-2025)
3.1.2 Global Radiolabelled ADME Studies Revenue Market Share by Players (2020-2025)
3.2 Global Radiolabelled ADME Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiolabelled ADME Studies Revenue
3.4 Global Radiolabelled ADME Studies Market Concentration Ratio
3.4.1 Global Radiolabelled ADME Studies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiolabelled ADME Studies Revenue in 2024
3.5 Global Key Players of Radiolabelled ADME Studies Head office and Area Served
3.6 Global Key Players of Radiolabelled ADME Studies, Product and Application
3.7 Global Key Players of Radiolabelled ADME Studies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiolabelled ADME Studies Breakdown Data by Type
4.1 Global Radiolabelled ADME Studies Historic Market Size by Type (2020-2025)
4.2 Global Radiolabelled ADME Studies Forecasted Market Size by Type (2026-2031)
5 Radiolabelled ADME Studies Breakdown Data by Application
5.1 Global Radiolabelled ADME Studies Historic Market Size by Application (2020-2025)
5.2 Global Radiolabelled ADME Studies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiolabelled ADME Studies Market Size (2020-2031)
6.2 North America Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiolabelled ADME Studies Market Size by Country (2020-2025)
6.4 North America Radiolabelled ADME Studies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiolabelled ADME Studies Market Size (2020-2031)
7.2 Europe Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiolabelled ADME Studies Market Size by Country (2020-2025)
7.4 Europe Radiolabelled ADME Studies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiolabelled ADME Studies Market Size (2020-2031)
8.2 Asia-Pacific Radiolabelled ADME Studies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiolabelled ADME Studies Market Size (2020-2031)
9.2 Latin America Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiolabelled ADME Studies Market Size by Country (2020-2025)
9.4 Latin America Radiolabelled ADME Studies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiolabelled ADME Studies Market Size (2020-2031)
10.2 Middle East & Africa Radiolabelled ADME Studies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiolabelled ADME Studies Introduction
11.1.4 Charles River Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Radiolabelled ADME Studies Introduction
11.2.4 Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Radiolabelled ADME Studies Introduction
11.3.4 Evotec Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.3.5 Evotec Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Details
11.4.2 Labcorp Business Overview
11.4.3 Labcorp Radiolabelled ADME Studies Introduction
11.4.4 Labcorp Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.4.5 Labcorp Recent Development
11.5 Sekisui Medical
11.5.1 Sekisui Medical Company Details
11.5.2 Sekisui Medical Business Overview
11.5.3 Sekisui Medical Radiolabelled ADME Studies Introduction
11.5.4 Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.5.5 Sekisui Medical Recent Development
11.6 XenoTech (BioIVT)
11.6.1 XenoTech (BioIVT) Company Details
11.6.2 XenoTech (BioIVT) Business Overview
11.6.3 XenoTech (BioIVT) Radiolabelled ADME Studies Introduction
11.6.4 XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.6.5 XenoTech (BioIVT) Recent Development
11.7 QPS
11.7.1 QPS Company Details
11.7.2 QPS Business Overview
11.7.3 QPS Radiolabelled ADME Studies Introduction
11.7.4 QPS Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.7.5 QPS Recent Development
11.8 BioDuro-Sundia
11.8.1 BioDuro-Sundia Company Details
11.8.2 BioDuro-Sundia Business Overview
11.8.3 BioDuro-Sundia Radiolabelled ADME Studies Introduction
11.8.4 BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.8.5 BioDuro-Sundia Recent Development
11.9 Quotient Sciences
11.9.1 Quotient Sciences Company Details
11.9.2 Quotient Sciences Business Overview
11.9.3 Quotient Sciences Radiolabelled ADME Studies Introduction
11.9.4 Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.9.5 Quotient Sciences Recent Development
11.10 Chelatec
11.10.1 Chelatec Company Details
11.10.2 Chelatec Business Overview
11.10.3 Chelatec Radiolabelled ADME Studies Introduction
11.10.4 Chelatec Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.10.5 Chelatec Recent Development
11.11 HMR
11.11.1 HMR Company Details
11.11.2 HMR Business Overview
11.11.3 HMR Radiolabelled ADME Studies Introduction
11.11.4 HMR Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.11.5 HMR Recent Development
11.12 Nuvisan
11.12.1 Nuvisan Company Details
11.12.2 Nuvisan Business Overview
11.12.3 Nuvisan Radiolabelled ADME Studies Introduction
11.12.4 Nuvisan Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.12.5 Nuvisan Recent Development
11.13 Fluorizon
11.13.1 Fluorizon Company Details
11.13.2 Fluorizon Business Overview
11.13.3 Fluorizon Radiolabelled ADME Studies Introduction
11.13.4 Fluorizon Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.13.5 Fluorizon Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Radiolabelled ADME Studies Introduction
11.14.4 WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.14.5 WuXi AppTec Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Radiolabelled ADME Studies Introduction
11.15.4 Pharmaron Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.15.5 Pharmaron Recent Development
11.16 InnoStar
11.16.1 InnoStar Company Details
11.16.2 InnoStar Business Overview
11.16.3 InnoStar Radiolabelled ADME Studies Introduction
11.16.4 InnoStar Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.16.5 InnoStar Recent Development
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Radiolabelled ADME Studies Introduction
11.17.4 Medicilon Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.17.5 Medicilon Recent Development
11.18 Frontage
11.18.1 Frontage Company Details
11.18.2 Frontage Business Overview
11.18.3 Frontage Radiolabelled ADME Studies Introduction
11.18.4 Frontage Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.18.5 Frontage Recent Development
11.19 Value Pharmaceutical
11.19.1 Value Pharmaceutical Company Details
11.19.2 Value Pharmaceutical Business Overview
11.19.3 Value Pharmaceutical Radiolabelled ADME Studies Introduction
11.19.4 Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.19.5 Value Pharmaceutical Recent Development
11.20 New Radiomedicine Technology
11.20.1 New Radiomedicine Technology Company Details
11.20.2 New Radiomedicine Technology Business Overview
11.20.3 New Radiomedicine Technology Radiolabelled ADME Studies Introduction
11.20.4 New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2020-2025)
11.20.5 New Radiomedicine Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radiolabelled ADME Studies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of C-14
Table 3. Key Players of H-3
Table 4. Key Players of Others
Table 5. Global Radiolabelled ADME Studies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Radiolabelled ADME Studies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Radiolabelled ADME Studies Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Radiolabelled ADME Studies Market Share by Region (2020-2025)
Table 9. Global Radiolabelled ADME Studies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Radiolabelled ADME Studies Market Share by Region (2026-2031)
Table 11. Radiolabelled ADME Studies Market Trends
Table 12. Radiolabelled ADME Studies Market Drivers
Table 13. Radiolabelled ADME Studies Market Challenges
Table 14. Radiolabelled ADME Studies Market Restraints
Table 15. Global Radiolabelled ADME Studies Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Radiolabelled ADME Studies Market Share by Players (2020-2025)
Table 17. Global Top Radiolabelled ADME Studies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2024)
Table 18. Ranking of Global Top Radiolabelled ADME Studies Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Radiolabelled ADME Studies Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Radiolabelled ADME Studies, Headquarters and Area Served
Table 21. Global Key Players of Radiolabelled ADME Studies, Product and Application
Table 22. Global Key Players of Radiolabelled ADME Studies, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Radiolabelled ADME Studies Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Radiolabelled ADME Studies Revenue Market Share by Type (2020-2025)
Table 26. Global Radiolabelled ADME Studies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Radiolabelled ADME Studies Revenue Market Share by Type (2026-2031)
Table 28. Global Radiolabelled ADME Studies Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Radiolabelled ADME Studies Revenue Market Share by Application (2020-2025)
Table 30. Global Radiolabelled ADME Studies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Radiolabelled ADME Studies Revenue Market Share by Application (2026-2031)
Table 32. North America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Radiolabelled ADME Studies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 47. Charles River Company Details
Table 48. Charles River Business Overview
Table 49. Charles River Radiolabelled ADME Studies Product
Table 50. Charles River Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 51. Charles River Recent Development
Table 52. Eurofins Scientific Company Details
Table 53. Eurofins Scientific Business Overview
Table 54. Eurofins Scientific Radiolabelled ADME Studies Product
Table 55. Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 56. Eurofins Scientific Recent Development
Table 57. Evotec Company Details
Table 58. Evotec Business Overview
Table 59. Evotec Radiolabelled ADME Studies Product
Table 60. Evotec Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 61. Evotec Recent Development
Table 62. Labcorp Company Details
Table 63. Labcorp Business Overview
Table 64. Labcorp Radiolabelled ADME Studies Product
Table 65. Labcorp Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 66. Labcorp Recent Development
Table 67. Sekisui Medical Company Details
Table 68. Sekisui Medical Business Overview
Table 69. Sekisui Medical Radiolabelled ADME Studies Product
Table 70. Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 71. Sekisui Medical Recent Development
Table 72. XenoTech (BioIVT) Company Details
Table 73. XenoTech (BioIVT) Business Overview
Table 74. XenoTech (BioIVT) Radiolabelled ADME Studies Product
Table 75. XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 76. XenoTech (BioIVT) Recent Development
Table 77. QPS Company Details
Table 78. QPS Business Overview
Table 79. QPS Radiolabelled ADME Studies Product
Table 80. QPS Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 81. QPS Recent Development
Table 82. BioDuro-Sundia Company Details
Table 83. BioDuro-Sundia Business Overview
Table 84. BioDuro-Sundia Radiolabelled ADME Studies Product
Table 85. BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 86. BioDuro-Sundia Recent Development
Table 87. Quotient Sciences Company Details
Table 88. Quotient Sciences Business Overview
Table 89. Quotient Sciences Radiolabelled ADME Studies Product
Table 90. Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 91. Quotient Sciences Recent Development
Table 92. Chelatec Company Details
Table 93. Chelatec Business Overview
Table 94. Chelatec Radiolabelled ADME Studies Product
Table 95. Chelatec Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 96. Chelatec Recent Development
Table 97. HMR Company Details
Table 98. HMR Business Overview
Table 99. HMR Radiolabelled ADME Studies Product
Table 100. HMR Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 101. HMR Recent Development
Table 102. Nuvisan Company Details
Table 103. Nuvisan Business Overview
Table 104. Nuvisan Radiolabelled ADME Studies Product
Table 105. Nuvisan Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 106. Nuvisan Recent Development
Table 107. Fluorizon Company Details
Table 108. Fluorizon Business Overview
Table 109. Fluorizon Radiolabelled ADME Studies Product
Table 110. Fluorizon Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 111. Fluorizon Recent Development
Table 112. WuXi AppTec Company Details
Table 113. WuXi AppTec Business Overview
Table 114. WuXi AppTec Radiolabelled ADME Studies Product
Table 115. WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 116. WuXi AppTec Recent Development
Table 117. Pharmaron Company Details
Table 118. Pharmaron Business Overview
Table 119. Pharmaron Radiolabelled ADME Studies Product
Table 120. Pharmaron Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 121. Pharmaron Recent Development
Table 122. InnoStar Company Details
Table 123. InnoStar Business Overview
Table 124. InnoStar Radiolabelled ADME Studies Product
Table 125. InnoStar Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 126. InnoStar Recent Development
Table 127. Medicilon Company Details
Table 128. Medicilon Business Overview
Table 129. Medicilon Radiolabelled ADME Studies Product
Table 130. Medicilon Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 131. Medicilon Recent Development
Table 132. Frontage Company Details
Table 133. Frontage Business Overview
Table 134. Frontage Radiolabelled ADME Studies Product
Table 135. Frontage Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 136. Frontage Recent Development
Table 137. Value Pharmaceutical Company Details
Table 138. Value Pharmaceutical Business Overview
Table 139. Value Pharmaceutical Radiolabelled ADME Studies Product
Table 140. Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 141. Value Pharmaceutical Recent Development
Table 142. New Radiomedicine Technology Company Details
Table 143. New Radiomedicine Technology Business Overview
Table 144. New Radiomedicine Technology Radiolabelled ADME Studies Product
Table 145. New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 146. New Radiomedicine Technology Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Radiolabelled ADME Studies Picture
Figure 2. Global Radiolabelled ADME Studies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiolabelled ADME Studies Market Share by Type: 2024 VS 2031
Figure 4. C-14 Features
Figure 5. H-3 Features
Figure 6. Others Features
Figure 7. Global Radiolabelled ADME Studies Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Radiolabelled ADME Studies Market Share by Application: 2024 VS 2031
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Government and Academic Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Radiolabelled ADME Studies Report Years Considered
Figure 13. Global Radiolabelled ADME Studies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Radiolabelled ADME Studies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Radiolabelled ADME Studies Market Share by Region: 2024 VS 2031
Figure 16. Global Radiolabelled ADME Studies Market Share by Players in 2024
Figure 17. Global Top Radiolabelled ADME Studies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Radiolabelled ADME Studies Revenue in 2024
Figure 19. North America Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 21. United States Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 25. Germany Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Radiolabelled ADME Studies Market Share by Region (2020-2031)
Figure 33. China Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 41. Mexico Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 45. Turkey Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Charles River Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 49. Eurofins Scientific Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 50. Evotec Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 51. Labcorp Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 52. Sekisui Medical Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 53. XenoTech (BioIVT) Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 54. QPS Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 55. BioDuro-Sundia Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 56. Quotient Sciences Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 57. Chelatec Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 58. HMR Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 59. Nuvisan Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 60. Fluorizon Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 62. Pharmaron Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 63. InnoStar Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 64. Medicilon Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 65. Frontage Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 66. Value Pharmaceutical Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 67. New Radiomedicine Technology Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Radiolabelled ADME Studies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of C-14
Table 3. Key Players of H-3
Table 4. Key Players of Others
Table 5. Global Radiolabelled ADME Studies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Radiolabelled ADME Studies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Radiolabelled ADME Studies Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Radiolabelled ADME Studies Market Share by Region (2020-2025)
Table 9. Global Radiolabelled ADME Studies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Radiolabelled ADME Studies Market Share by Region (2026-2031)
Table 11. Radiolabelled ADME Studies Market Trends
Table 12. Radiolabelled ADME Studies Market Drivers
Table 13. Radiolabelled ADME Studies Market Challenges
Table 14. Radiolabelled ADME Studies Market Restraints
Table 15. Global Radiolabelled ADME Studies Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Radiolabelled ADME Studies Market Share by Players (2020-2025)
Table 17. Global Top Radiolabelled ADME Studies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2024)
Table 18. Ranking of Global Top Radiolabelled ADME Studies Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Radiolabelled ADME Studies Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Radiolabelled ADME Studies, Headquarters and Area Served
Table 21. Global Key Players of Radiolabelled ADME Studies, Product and Application
Table 22. Global Key Players of Radiolabelled ADME Studies, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Radiolabelled ADME Studies Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Radiolabelled ADME Studies Revenue Market Share by Type (2020-2025)
Table 26. Global Radiolabelled ADME Studies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Radiolabelled ADME Studies Revenue Market Share by Type (2026-2031)
Table 28. Global Radiolabelled ADME Studies Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Radiolabelled ADME Studies Revenue Market Share by Application (2020-2025)
Table 30. Global Radiolabelled ADME Studies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Radiolabelled ADME Studies Revenue Market Share by Application (2026-2031)
Table 32. North America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Radiolabelled ADME Studies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Radiolabelled ADME Studies Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Radiolabelled ADME Studies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Radiolabelled ADME Studies Market Size by Country (2026-2031) & (US$ Million)
Table 47. Charles River Company Details
Table 48. Charles River Business Overview
Table 49. Charles River Radiolabelled ADME Studies Product
Table 50. Charles River Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 51. Charles River Recent Development
Table 52. Eurofins Scientific Company Details
Table 53. Eurofins Scientific Business Overview
Table 54. Eurofins Scientific Radiolabelled ADME Studies Product
Table 55. Eurofins Scientific Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 56. Eurofins Scientific Recent Development
Table 57. Evotec Company Details
Table 58. Evotec Business Overview
Table 59. Evotec Radiolabelled ADME Studies Product
Table 60. Evotec Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 61. Evotec Recent Development
Table 62. Labcorp Company Details
Table 63. Labcorp Business Overview
Table 64. Labcorp Radiolabelled ADME Studies Product
Table 65. Labcorp Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 66. Labcorp Recent Development
Table 67. Sekisui Medical Company Details
Table 68. Sekisui Medical Business Overview
Table 69. Sekisui Medical Radiolabelled ADME Studies Product
Table 70. Sekisui Medical Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 71. Sekisui Medical Recent Development
Table 72. XenoTech (BioIVT) Company Details
Table 73. XenoTech (BioIVT) Business Overview
Table 74. XenoTech (BioIVT) Radiolabelled ADME Studies Product
Table 75. XenoTech (BioIVT) Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 76. XenoTech (BioIVT) Recent Development
Table 77. QPS Company Details
Table 78. QPS Business Overview
Table 79. QPS Radiolabelled ADME Studies Product
Table 80. QPS Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 81. QPS Recent Development
Table 82. BioDuro-Sundia Company Details
Table 83. BioDuro-Sundia Business Overview
Table 84. BioDuro-Sundia Radiolabelled ADME Studies Product
Table 85. BioDuro-Sundia Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 86. BioDuro-Sundia Recent Development
Table 87. Quotient Sciences Company Details
Table 88. Quotient Sciences Business Overview
Table 89. Quotient Sciences Radiolabelled ADME Studies Product
Table 90. Quotient Sciences Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 91. Quotient Sciences Recent Development
Table 92. Chelatec Company Details
Table 93. Chelatec Business Overview
Table 94. Chelatec Radiolabelled ADME Studies Product
Table 95. Chelatec Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 96. Chelatec Recent Development
Table 97. HMR Company Details
Table 98. HMR Business Overview
Table 99. HMR Radiolabelled ADME Studies Product
Table 100. HMR Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 101. HMR Recent Development
Table 102. Nuvisan Company Details
Table 103. Nuvisan Business Overview
Table 104. Nuvisan Radiolabelled ADME Studies Product
Table 105. Nuvisan Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 106. Nuvisan Recent Development
Table 107. Fluorizon Company Details
Table 108. Fluorizon Business Overview
Table 109. Fluorizon Radiolabelled ADME Studies Product
Table 110. Fluorizon Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 111. Fluorizon Recent Development
Table 112. WuXi AppTec Company Details
Table 113. WuXi AppTec Business Overview
Table 114. WuXi AppTec Radiolabelled ADME Studies Product
Table 115. WuXi AppTec Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 116. WuXi AppTec Recent Development
Table 117. Pharmaron Company Details
Table 118. Pharmaron Business Overview
Table 119. Pharmaron Radiolabelled ADME Studies Product
Table 120. Pharmaron Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 121. Pharmaron Recent Development
Table 122. InnoStar Company Details
Table 123. InnoStar Business Overview
Table 124. InnoStar Radiolabelled ADME Studies Product
Table 125. InnoStar Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 126. InnoStar Recent Development
Table 127. Medicilon Company Details
Table 128. Medicilon Business Overview
Table 129. Medicilon Radiolabelled ADME Studies Product
Table 130. Medicilon Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 131. Medicilon Recent Development
Table 132. Frontage Company Details
Table 133. Frontage Business Overview
Table 134. Frontage Radiolabelled ADME Studies Product
Table 135. Frontage Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 136. Frontage Recent Development
Table 137. Value Pharmaceutical Company Details
Table 138. Value Pharmaceutical Business Overview
Table 139. Value Pharmaceutical Radiolabelled ADME Studies Product
Table 140. Value Pharmaceutical Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 141. Value Pharmaceutical Recent Development
Table 142. New Radiomedicine Technology Company Details
Table 143. New Radiomedicine Technology Business Overview
Table 144. New Radiomedicine Technology Radiolabelled ADME Studies Product
Table 145. New Radiomedicine Technology Revenue in Radiolabelled ADME Studies Business (2020-2025) & (US$ Million)
Table 146. New Radiomedicine Technology Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Radiolabelled ADME Studies Picture
Figure 2. Global Radiolabelled ADME Studies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiolabelled ADME Studies Market Share by Type: 2024 VS 2031
Figure 4. C-14 Features
Figure 5. H-3 Features
Figure 6. Others Features
Figure 7. Global Radiolabelled ADME Studies Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Radiolabelled ADME Studies Market Share by Application: 2024 VS 2031
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Government and Academic Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Radiolabelled ADME Studies Report Years Considered
Figure 13. Global Radiolabelled ADME Studies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Radiolabelled ADME Studies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Radiolabelled ADME Studies Market Share by Region: 2024 VS 2031
Figure 16. Global Radiolabelled ADME Studies Market Share by Players in 2024
Figure 17. Global Top Radiolabelled ADME Studies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Radiolabelled ADME Studies Revenue in 2024
Figure 19. North America Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 21. United States Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 25. Germany Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Radiolabelled ADME Studies Market Share by Region (2020-2031)
Figure 33. China Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 41. Mexico Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Radiolabelled ADME Studies Market Share by Country (2020-2031)
Figure 45. Turkey Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Radiolabelled ADME Studies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Charles River Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 49. Eurofins Scientific Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 50. Evotec Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 51. Labcorp Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 52. Sekisui Medical Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 53. XenoTech (BioIVT) Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 54. QPS Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 55. BioDuro-Sundia Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 56. Quotient Sciences Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 57. Chelatec Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 58. HMR Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 59. Nuvisan Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 60. Fluorizon Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 62. Pharmaron Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 63. InnoStar Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 64. Medicilon Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 65. Frontage Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 66. Value Pharmaceutical Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 67. New Radiomedicine Technology Revenue Growth Rate in Radiolabelled ADME Studies Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232